UCM is boring again so I was poking around this weekend to find something.While I was aware that audit/corruption investigations caused Sihuan to be suspended for a year I only just found the below note that clarified a bit more of what happened.
https://www.fidelity.com.au/insights/esg/corporate-governance-case-study-sihuan-pharmaceuticals/
Goes to show the risk of distribution in China. Also, on an unrelated note (pun not intended), is Teresa related to Weicheng Guo…? I know Guo is a common name and the only link is she is Meng's appointment, but I guess it wouldn't be a bad thing.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.861M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 62000 | 2 |
View Market Depth
| Last trade - 16.21pm 11/08/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable